Entry - #214400 - CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A - OMIM
# 214400

CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A


Alternative titles; symbols

CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4A
CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4A


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
8q21.11 Charcot-Marie-Tooth disease, type 4A 214400 AR 3 GDAP1 606598
Clinical Synopsis
 
Phenotypic Series
 

INHERITANCE
- Autosomal recessive
SKELETAL
Spine
- Kyphoscoliosis (in some patients)
Hands
- Claw hand deformities (in severe cases)
Feet
- Foot deformities (in some patients)
NEUROLOGIC
Peripheral Nervous System
- Delayed motor development
- Distal limb muscle weakness due to peripheral neuropathy
- Distal limb muscle atrophy due to peripheral neuropathy
- Distal sensory impairment
- Hyporeflexia
- Areflexia
- Inability to walk by childhood/adolescence
- Decreased motor nerve conduction velocity (NCV) (less than 38 m/s)
- Hypertrophic nerve changes
- Basal lamina 'onion bulb' formations seen on nerve biopsy
- Decreased number of myelinated fibers
- Hypomyelination
MISCELLANEOUS
- Onset before age 2 years
- Usually begins in feet and legs (peroneal distribution)
- Upper limb involvement usually occurs later
- May progress to involve proximal muscles
- Rapid progression to disability
- Axonal features may coexist (normal NCV, axonal degeneration on biopsy)
- Genetic heterogeneity
MOLECULAR BASIS
- Caused by mutation in the ganglioside-induced differentiation-associated protein-1 gene (GDAP1, 606589.0001)
Charcot-Marie-Tooth disease - PS118220 - 81 Entries
Location Phenotype Inheritance Phenotype
mapping key
Phenotype
MIM number
Gene/Locus Gene/Locus
MIM number
1p36.31 Charcot-Marie-Tooth disease, recessive intermediate C AR 3 615376 PLEKHG5 611101
1p36.22 Charcot-Marie-Tooth disease, type 2A1 AD 3 118210 KIF1B 605995
1p36.22 Hereditary motor and sensory neuropathy VIA AD 3 601152 MFN2 608507
1p36.22 Charcot-Marie-Tooth disease, axonal, type 2A2B AR 3 617087 MFN2 608507
1p36.22 Charcot-Marie-Tooth disease, axonal, type 2A2A AD 3 609260 MFN2 608507
1p35.1 Charcot-Marie-Tooth disease, dominant intermediate C AD 3 608323 YARS1 603623
1p13.1 Charcot-Marie-Tooth disease, axonal, type 2DD AD 3 618036 ATP1A1 182310
1q22 Charcot-Marie-Tooth disease, type 2B1 AR 3 605588 LMNA 150330
1q23.2 Charcot-Marie-Tooth disease, axonal, type 2FF AD 3 619519 CADM3 609743
1q23.3 Dejerine-Sottas disease AD, AR 3 145900 MPZ 159440
1q23.3 Charcot-Marie-Tooth disease, type 1B AD 3 118200 MPZ 159440
1q23.3 Charcot-Marie-Tooth disease, type 2I AD 3 607677 MPZ 159440
1q23.3 Charcot-Marie-Tooth disease, dominant intermediate D AD 3 607791 MPZ 159440
1q23.3 Charcot-Marie-Tooth disease, type 2J AD 3 607736 MPZ 159440
2p23.3 Charcot-Marie-Tooth disease, axonal, type 2EE AR 3 618400 MPV17 137960
3q21.3 Charcot-Marie-Tooth disease, type 2B AD 3 600882 RAB7 602298
3q25.2 Charcot-Marie-Tooth disease, axonal, type 2T AD, AR 3 617017 MME 120520
3q26.33 Charcot-Marie-Tooth disease, dominant intermediate F AD 3 615185 GNB4 610863
4q31.3 Charcot-Marie-Tooth disease, type 2R AR 3 615490 TRIM2 614141
5q31.3 Charcot-Marie-Tooth disease, axonal, type 2W AD 3 616625 HARS1 142810
5q32 Charcot-Marie-Tooth disease, type 4C AR 3 601596 SH3TC2 608206
6p21.31 Charcot-Marie-Tooth disease, demyelinating, type 1J AD 3 620111 ITPR3 147267
6q21 Charcot-Marie-Tooth disease, type 4J AR 3 611228 FIG4 609390
7p14.3 Charcot-Marie-Tooth disease, type 2D AD 3 601472 GARS1 600287
7q11.23 Charcot-Marie-Tooth disease, axonal, type 2F AD 3 606595 HSPB1 602195
8p21.2 Charcot-Marie-Tooth disease, type 1F AD, AR 3 607734 NEFL 162280
8p21.2 Charcot-Marie-Tooth disease, dominant intermediate G AD 3 617882 NEFL 162280
8p21.2 Charcot-Marie-Tooth disease, type 2E AD 3 607684 NEFL 162280
8q13-q23 Charcot-Marie-Tooth disease, axonal, type 2H AR 2 607731 CMT2H 607731
8q21.11 ?Charcot-Marie-Tooth disease, axonal, autosomal dominant, type 2K AD, AR 3 607831 JPH1 605266
8q21.11 Charcot-Marie-Tooth disease, type 4A AR 3 214400 GDAP1 606598
8q21.11 Charcot-Marie-Tooth disease, recessive intermediate, A AR 3 608340 GDAP1 606598
8q21.11 Charcot-Marie-Tooth disease, axonal, with vocal cord paresis AR 3 607706 GDAP1 606598
8q21.11 Charcot-Marie-Tooth disease, axonal, type 2K AD, AR 3 607831 GDAP1 606598
8q21.13 Charcot-Marie-Tooth disease, demyelinating, type 1G AD 3 618279 PMP2 170715
8q24.22 Charcot-Marie-Tooth disease, type 4D AR 3 601455 NDRG1 605262
9p13.3 Charcot-Marie-Tooth disease, type 2Y AD 3 616687 VCP 601023
9q33.3-q34.11 Charcot-Marie-Tooth disease, axonal, type 2P AD, AR 3 614436 LRSAM1 610933
9q34.2 Charcot-Marie-Tooth disease, type 4K AR 3 616684 SURF1 185620
10p14 ?Charcot-Marie-Tooth disease, axonal, type 2Q AD 3 615025 DHTKD1 614984
10q21.3 Charcot-Marie-Tooth disease, type 1D AD 3 607678 EGR2 129010
10q21.3 Dejerine-Sottas disease AD, AR 3 145900 EGR2 129010
10q21.3 Hypomyelinating neuropathy, congenital, 1 AD, AR 3 605253 EGR2 129010
10q22.1 Neuropathy, hereditary motor and sensory, Russe type AR 3 605285 HK1 142600
10q24.32 Charcot-Marie-Tooth disease, axonal, type 2GG AD 3 606483 GBF1 603698
11p15.4 Charcot-Marie-Tooth disease, type 4B2 AR 3 604563 SBF2 607697
11q13.3 Charcot-Marie-Tooth disease, axonal, type 2S AR 3 616155 IGHMBP2 600502
11q21 Charcot-Marie-Tooth disease, type 4B1 AR 3 601382 MTMR2 603557
12p11.21 Charcot-Marie-Tooth disease, type 4H AR 3 609311 FGD4 611104
12q13.3 Charcot-Marie-Tooth disease, axonal, type 2U AD 3 616280 MARS1 156560
12q23.3 Charcot-Marie-Tooth disease, demyelinating, type 1I AD 3 619742 POLR3B 614366
12q24.11 Hereditary motor and sensory neuropathy, type IIc AD 3 606071 TRPV4 605427
12q24.23 Charcot-Marie-Tooth disease, axonal, type 2L AD 3 608673 HSPB8 608014
12q24.31 Charcot-Marie-Tooth disease, recessive intermediate D AR 3 616039 COX6A1 602072
14q32.12 Charcot-Marie-Tooth disease, demyelinating, type 1H AD 3 619764 FBLN5 604580
14q32.31 Charcot-Marie-Tooth disease, axonal, type 2O AD 3 614228 DYNC1H1 600112
14q32.33 Charcot-Marie-Tooth disease, dominant intermediate E AD 3 614455 INF2 610982
15q14 Charcot-Marie-Tooth disease, axonal, type 2II AD 3 620068 SLC12A6 604878
15q21.1 Charcot-Marie-Tooth disease, axonal, type 2X AR 3 616668 SPG11 610844
16p13.13 Charcot-Marie-Tooth disease, type 1C AD 3 601098 LITAF 603795
16q22.1 Charcot-Marie-Tooth disease, axonal, type 2N AD 3 613287 AARS1 601065
16q23.1 ?Charcot-Marie-Tooth disease, recessive intermediate, B AR 3 613641 KARS1 601421
17p12 Dejerine-Sottas disease AD, AR 3 145900 PMP22 601097
17p12 Charcot-Marie-Tooth disease, type 1E AD 3 118300 PMP22 601097
17p12 Charcot-Marie-Tooth disease, type 1A AD 3 118220 PMP22 601097
17q21.2 ?Charcot-Marie-Tooth disease, axonal, type 2V AD 3 616491 NAGLU 609701
19p13.2 Charcot-Marie-Tooth disease, dominant intermediate B AD 3 606482 DNM2 602378
19p13.2 Charcot-Marie-Tooth disease, axonal type 2M AD 3 606482 DNM2 602378
19q13.2 Charcot-Marie-Tooth disease, type 4F AR 3 614895 PRX 605725
19q13.2 Dejerine-Sottas disease AD, AR 3 145900 PRX 605725
19q13.33 ?Charcot-Marie-Tooth disease, type 2B2 AR 3 605589 PNKP 605610
20p12.2 Charcot-Marie-Tooth disease, axonal, type 2HH AD 3 619574 JAG1 601920
22q12.2 Charcot-Marie-Tooth disease, axonal, type 2CC AD 3 616924 NEFH 162230
22q12.2 Charcot-Marie-Tooth disease, axonal, type 2Z AD 3 616688 MORC2 616661
22q13.33 Charcot-Marie-Tooth disease, type 4B3 AR 3 615284 SBF1 603560
Xp22.2 Charcot-Marie-Tooth neuropathy, X-linked recessive, 2 XLR 2 302801 CMTX2 302801
Xp22.11 ?Charcot-Marie-Tooth disease, X-linked dominant, 6 XLD 3 300905 PDK3 300906
Xq13.1 Charcot-Marie-Tooth neuropathy, X-linked dominant, 1 XLD 3 302800 GJB1 304040
Xq22.3 Charcot-Marie-Tooth disease, X-linked recessive, 5 XLR 3 311070 PRPS1 311850
Xq26 Charcot-Marie-Tooth neuropathy, X-linked recessive, 3 XLR 4 302802 CMTX3 302802
Xq26.1 Cowchock syndrome XLR 3 310490 AIFM1 300169

TEXT

A number sign (#) is used with this entry because autosomal recessive demyelinating Charcot-Marie-Tooth disease type 4A (CMT4A) is caused by homozygous mutation in the GDAP1 gene (606598), which encodes ganglioside-induced differentiation-associated protein-1, on chromosome 8q21.

Mutations in the GDAP1 gene also cause select forms of autosomal recessive axonal neuropathy (e.g., 607706 and CMT2K, 607831) as well as an intermediate form of CMT (CMTRIA; 608340). Mutations in the GDAP1 gene may also cause the axonal form CMT2H (607731) because the locus for that disorder has been mapped to 8q21.


Description

By convention, the designation CMT4 is applied to autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease, which is a peripheral neuropathy characterized by distal motor and sensory impairment resulting in gait difficulties and associated with foot deformities. Motor nerve conduction velocities are decreased, and sural nerve biopsies show loss of myelinated fibers. The age at onset and severity is variable (summary by Patzko and Shy, 2012).

Genetic Heterogeneity of Charcot-Marie-Tooth Disease Type 4

Several different subtypes of autosomal recessive demyelinating CMT (CMT4) have been identified, each with particular ethnic, pathologic, or clinical characteristics: CMT4A; CMT4B, which includes CMT4B1 (601382), caused by mutation in the MTMR2 gene (603557), CMT4B2 (604563), caused by mutation in the SBF2 gene (607697), and CMT4B3 (615284), caused by mutation in the SBF1 gene (603560); CMT4C (601596), caused by mutation in the SH3TC2 gene (608206); CMT4D (601455), caused by mutation in the NDRG1 gene (605262); CMT4E (605253), caused by mutation in the EGR2 (129010) or MPZ (159440) genes; CMT4F (614895), caused by mutation in the PRX gene (605725); CMT4G, or Russe-type hereditary motor and sensory neuropathy, (605285), which maps to chromosome 10q23; CMT4H (609311), caused by mutation in the FGD4 gene (611104); CMT4J (611228), caused by mutation in the FIG4 gene (609390); and CMT4K (616684), caused by mutation in the SURF1 gene (185620).


Clinical Features

Allan (1939) found 8 young girls with a recessive form of peroneal atrophy in a North Carolina orthopedic hospital which catered to patients under the age of 16 years. The 8 came from 6 families in which both parents were normal. In 4 of the 6 families the parents were cousins. Beighton (1971) described 9 (possibly 10) cases of recessive CMT disease in an inbred Amish group. Identical twins were concordantly affected.

Ben Othmane et al. (1993, 1993) reported 4 Tunisian families with a homogeneous form of autosomal recessive demyelinating CMT. The disorder, which they designated type 4A, was a severe neuropathy of childhood characterized by early age of onset (before 2 years of age), rapidly progressive distal weakness and atrophy of the limbs leading to an inability to walk in late childhood or adolescence, mild sensory loss with abolished deep tendon reflexes, normal cerebrospinal fluid, severely decreased motor nerve conduction velocity (NCV), and hypomyelination.


Mapping

By genetic linkage studies, Ben Othmane et al. (1993, 1993) mapped the CMT4 gene to 8q-q21.1. A two-point peak lod score of 9.19 at theta = 0.00 was obtained for D8S164. The gene encoding peripheral myelin protein-2 (PMP2; 170715) maps to the same area and was, therefore, a candidate for the site of the mutation in this disorder. Ben Othmane et al. (1995) demonstrated, however, that the PMP2 gene lies distal to the CMT4A gene region. Using a PAC contig and haplotype analysis, Ben Othmane et al. (1998) further narrowed the assignment of the CMT4A locus.


Inheritance

The transmission pattern of CMT4A in the families reported by Ben Othmane et al. (1993, 1993) and studied by Baxter et al. (2002) was consistent with autosomal recessive inheritance.


Molecular Genetics

By positional cloning, Baxter et al. (2002) identified the GDAP1 gene as the site of 3 different homozygous mutations (606598.0001-606598.0003) in the 4 Tunisian families with CMT4A reported by Ben Othmane et al. (1993, 1993).

See comments of Nicholson and Ouvrier (2002) concerning the mixed axonal and demyelinating type of CMT resulting from GDAP1 mutations.


Population Genetics

The autosomal recessive form of demyelinating CMT is less frequent than the dominant (118200, 118210) or X-linked recessive (302801) forms. Peroneal atrophy is one of the conditions used by Allan (1939) to illustrate the 'law' that recessive disorders are more severe than dominant ones and that X-linked disorders tend to be intermediate in severity. This disorder may have been unusually frequent in the hill folk of the western part of North Carolina where Allan worked.

In western Norway, Skre (1974) estimated the frequency of the 3 types of CMT as follows: autosomal dominant, 36 per 100,000; autosomal recessive, 1.4 per 100,000; X-linked recessive, 3.6 per 100,000. His discussion of the autosomal recessive form was particularly useful. He concluded that it is a more generalized disorder than the other two forms.


History

Mahloudji (1969) described 2 sisters and a brother, born of consanguineous Iranian parents, with early childhood onset of a sensorimotor polyneuropathy. The 2 older sibs, sister and brother, were ages 17 and 18.5 years, respectively, at the time of the report. Both had delayed motor development, achieving walking at age 3 to 4 years. Gait was also awkward, with frequent falls, and Romberg sign was positive. Physical examination showed absence of all deep tendon reflexes and superficial abdominal reflexes. There was distal impairment of all sensory modalities affecting both the upper and lower limbs, which was more severe in the sister, extending up to her knees and thighs. Neither had muscle wasting, but both had mild weakness in the distal muscles, more prominent in the lower limbs. Cranial nerves were intact, intelligence was normal, and there were no foot deformities or dysarthria. The brother had scoliosis of the thoracic side and a supernumerary nipple on the right. The youngest 7-year-old sister had delayed development, abnormal gait, areflexia, and was unable to run.


REFERENCES

  1. Allan, W. Relation of hereditary pattern to clinical severity as illustrated by peroneal atrophy. Arch. Intern. Med. 63: 1123-1131, 1939.

  2. Baxter, R. V., Ben Othmane, K., Rochelle, J. M., Stajich, J. E., Hulette, C., Dew-Knight, S., Hentati, F., Ben Hamida, M., Bel, S., Stenger, J. E., Gilbert, J. R., Pericak-Vance, M. A., Vance, J. M. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nature Genet. 30: 21-22, 2002. [PubMed: 11743579, related citations] [Full Text]

  3. Beighton, P. H. Recessively inherited Charcot-Marie-Tooth syndrome in identical twins. Birth Defects Orig. Art. Ser. VII(2): 105, 1971. [PubMed: 5173114, related citations]

  4. Ben Othmane, K. B., Rochelle, J. M., Hamida, M. B., Slotterbeck, B., Rao, N., Hentati, F., Pericak-Vance, M. A., Vance, J.M. Fine localization of the CMT4A locus using a PAC contig and haplotype analysis. Neurogenetics 2: 18-23, 1998. [PubMed: 9933296, related citations] [Full Text]

  5. Ben Othmane, K., Ben Hamida, M., Lennon, F., Loeb, D., Hentati, F., Ben Hamida, C., Blel, S., Pericak-Vance, M. A., Vance, J. M. Autosomal recessive Charcot-Marie-Tooth disease (CMT4) type A: evidence of genetic linkage to chromosome 8q21. (Abstract) Am. J. Hum. Genet. 53 (suppl.): A149, 1993.

  6. Ben Othmane, K., Hentati, F., Lennon, F., Ben Hamida, C., Blel, S., Roses, A. D., Pericak-Vance, M. A., Ben Hamida, M., Vance, J. M. Linkage of a locus (CMT4A) for autosomal recessive Charcot-Marie-Tooth disease to chromosome 8q. Hum. Molec. Genet. 2: 1625-1628, 1993. [PubMed: 8268915, related citations] [Full Text]

  7. Ben Othmane, K., Loeb, D., Hayworth-Hodgte, R., Hentati, F., Rao, N., Roses, A. D., Ben Hamida, M., Pericak-Vance, M. A., Vance, J. M. Physical and genetic mapping of the CMT4A locus and exclusion of PMP-2 as the defect in CMT4A. Genomics 28: 286-290, 1995. [PubMed: 8530038, related citations] [Full Text]

  8. Mahloudji, M. A recessively inherited mixed polyneuropathy of early onset. J. Med. Genet. 6: 411-412, 1969. [PubMed: 5365950, related citations] [Full Text]

  9. Nicholson, G., Ouvrier, R. GDAP1 mutations in CMT4: axonal and demyelinating phenotypes? (Editorial) Neurology 59: 1835-1836, 2002. [PubMed: 12499472, related citations] [Full Text]

  10. Patzko, A., Shy, M. E. Charcot-Marie-Tooth disease and related genetic neuropathies. Continuum (Minneap. Minn.) 18: 39-59, 2012. [PubMed: 22810069, related citations] [Full Text]

  11. Skre, H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin. Genet. 6: 98-118, 1974. [PubMed: 4430158, related citations] [Full Text]


Cassandra L. Kniffin - updated : 10/22/2012
Cassandra L. Kniffin - reorganized : 5/9/2003
Victor A. McKusick - updated : 1/21/2003
Victor A. McKusick - updated : 1/8/2002
Victor A. McKusick - updated : 4/12/1999
Creation Date:
Victor A. McKusick : 6/3/1986
carol : 01/03/2024
carol : 12/15/2015
ckniffin : 12/10/2015
alopez : 6/27/2013
ckniffin : 6/25/2013
carol : 10/23/2012
terry : 10/23/2012
ckniffin : 10/22/2012
ckniffin : 4/13/2011
carol : 4/22/2005
ckniffin : 4/20/2005
carol : 4/19/2005
wwang : 4/18/2005
ckniffin : 4/15/2005
ckniffin : 4/20/2004
carol : 12/12/2003
ckniffin : 12/12/2003
ckniffin : 5/29/2003
carol : 5/9/2003
ckniffin : 5/9/2003
ckniffin : 5/2/2003
ckniffin : 4/24/2003
ckniffin : 4/23/2003
ckniffin : 4/14/2003
cwells : 1/27/2003
tkritzer : 1/21/2003
terry : 3/22/2002
alopez : 1/9/2002
alopez : 1/9/2002
terry : 1/8/2002
carol : 5/18/2001
carol : 9/13/2000
carol : 4/12/1999
mark : 8/15/1996
mark : 3/5/1996
mark : 8/25/1995
carol : 6/16/1994
mimadm : 4/17/1994
warfield : 3/11/1994
carol : 10/18/1993
carol : 10/13/1993

# 214400

CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A


Alternative titles; symbols

CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE 4A
CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4A


SNOMEDCT: 715796006;   ORPHA: 99948;   DO: 0110185;  


Phenotype-Gene Relationships

Location Phenotype Phenotype
MIM number
Inheritance Phenotype
mapping key
Gene/Locus Gene/Locus
MIM number
8q21.11 Charcot-Marie-Tooth disease, type 4A 214400 Autosomal recessive 3 GDAP1 606598

TEXT

A number sign (#) is used with this entry because autosomal recessive demyelinating Charcot-Marie-Tooth disease type 4A (CMT4A) is caused by homozygous mutation in the GDAP1 gene (606598), which encodes ganglioside-induced differentiation-associated protein-1, on chromosome 8q21.

Mutations in the GDAP1 gene also cause select forms of autosomal recessive axonal neuropathy (e.g., 607706 and CMT2K, 607831) as well as an intermediate form of CMT (CMTRIA; 608340). Mutations in the GDAP1 gene may also cause the axonal form CMT2H (607731) because the locus for that disorder has been mapped to 8q21.


Description

By convention, the designation CMT4 is applied to autosomal recessive forms of demyelinating Charcot-Marie-Tooth disease, which is a peripheral neuropathy characterized by distal motor and sensory impairment resulting in gait difficulties and associated with foot deformities. Motor nerve conduction velocities are decreased, and sural nerve biopsies show loss of myelinated fibers. The age at onset and severity is variable (summary by Patzko and Shy, 2012).

Genetic Heterogeneity of Charcot-Marie-Tooth Disease Type 4

Several different subtypes of autosomal recessive demyelinating CMT (CMT4) have been identified, each with particular ethnic, pathologic, or clinical characteristics: CMT4A; CMT4B, which includes CMT4B1 (601382), caused by mutation in the MTMR2 gene (603557), CMT4B2 (604563), caused by mutation in the SBF2 gene (607697), and CMT4B3 (615284), caused by mutation in the SBF1 gene (603560); CMT4C (601596), caused by mutation in the SH3TC2 gene (608206); CMT4D (601455), caused by mutation in the NDRG1 gene (605262); CMT4E (605253), caused by mutation in the EGR2 (129010) or MPZ (159440) genes; CMT4F (614895), caused by mutation in the PRX gene (605725); CMT4G, or Russe-type hereditary motor and sensory neuropathy, (605285), which maps to chromosome 10q23; CMT4H (609311), caused by mutation in the FGD4 gene (611104); CMT4J (611228), caused by mutation in the FIG4 gene (609390); and CMT4K (616684), caused by mutation in the SURF1 gene (185620).


Clinical Features

Allan (1939) found 8 young girls with a recessive form of peroneal atrophy in a North Carolina orthopedic hospital which catered to patients under the age of 16 years. The 8 came from 6 families in which both parents were normal. In 4 of the 6 families the parents were cousins. Beighton (1971) described 9 (possibly 10) cases of recessive CMT disease in an inbred Amish group. Identical twins were concordantly affected.

Ben Othmane et al. (1993, 1993) reported 4 Tunisian families with a homogeneous form of autosomal recessive demyelinating CMT. The disorder, which they designated type 4A, was a severe neuropathy of childhood characterized by early age of onset (before 2 years of age), rapidly progressive distal weakness and atrophy of the limbs leading to an inability to walk in late childhood or adolescence, mild sensory loss with abolished deep tendon reflexes, normal cerebrospinal fluid, severely decreased motor nerve conduction velocity (NCV), and hypomyelination.


Mapping

By genetic linkage studies, Ben Othmane et al. (1993, 1993) mapped the CMT4 gene to 8q-q21.1. A two-point peak lod score of 9.19 at theta = 0.00 was obtained for D8S164. The gene encoding peripheral myelin protein-2 (PMP2; 170715) maps to the same area and was, therefore, a candidate for the site of the mutation in this disorder. Ben Othmane et al. (1995) demonstrated, however, that the PMP2 gene lies distal to the CMT4A gene region. Using a PAC contig and haplotype analysis, Ben Othmane et al. (1998) further narrowed the assignment of the CMT4A locus.


Inheritance

The transmission pattern of CMT4A in the families reported by Ben Othmane et al. (1993, 1993) and studied by Baxter et al. (2002) was consistent with autosomal recessive inheritance.


Molecular Genetics

By positional cloning, Baxter et al. (2002) identified the GDAP1 gene as the site of 3 different homozygous mutations (606598.0001-606598.0003) in the 4 Tunisian families with CMT4A reported by Ben Othmane et al. (1993, 1993).

See comments of Nicholson and Ouvrier (2002) concerning the mixed axonal and demyelinating type of CMT resulting from GDAP1 mutations.


Population Genetics

The autosomal recessive form of demyelinating CMT is less frequent than the dominant (118200, 118210) or X-linked recessive (302801) forms. Peroneal atrophy is one of the conditions used by Allan (1939) to illustrate the 'law' that recessive disorders are more severe than dominant ones and that X-linked disorders tend to be intermediate in severity. This disorder may have been unusually frequent in the hill folk of the western part of North Carolina where Allan worked.

In western Norway, Skre (1974) estimated the frequency of the 3 types of CMT as follows: autosomal dominant, 36 per 100,000; autosomal recessive, 1.4 per 100,000; X-linked recessive, 3.6 per 100,000. His discussion of the autosomal recessive form was particularly useful. He concluded that it is a more generalized disorder than the other two forms.


History

Mahloudji (1969) described 2 sisters and a brother, born of consanguineous Iranian parents, with early childhood onset of a sensorimotor polyneuropathy. The 2 older sibs, sister and brother, were ages 17 and 18.5 years, respectively, at the time of the report. Both had delayed motor development, achieving walking at age 3 to 4 years. Gait was also awkward, with frequent falls, and Romberg sign was positive. Physical examination showed absence of all deep tendon reflexes and superficial abdominal reflexes. There was distal impairment of all sensory modalities affecting both the upper and lower limbs, which was more severe in the sister, extending up to her knees and thighs. Neither had muscle wasting, but both had mild weakness in the distal muscles, more prominent in the lower limbs. Cranial nerves were intact, intelligence was normal, and there were no foot deformities or dysarthria. The brother had scoliosis of the thoracic side and a supernumerary nipple on the right. The youngest 7-year-old sister had delayed development, abnormal gait, areflexia, and was unable to run.


REFERENCES

  1. Allan, W. Relation of hereditary pattern to clinical severity as illustrated by peroneal atrophy. Arch. Intern. Med. 63: 1123-1131, 1939.

  2. Baxter, R. V., Ben Othmane, K., Rochelle, J. M., Stajich, J. E., Hulette, C., Dew-Knight, S., Hentati, F., Ben Hamida, M., Bel, S., Stenger, J. E., Gilbert, J. R., Pericak-Vance, M. A., Vance, J. M. Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21. Nature Genet. 30: 21-22, 2002. [PubMed: 11743579] [Full Text: https://doi.org/10.1038/ng796]

  3. Beighton, P. H. Recessively inherited Charcot-Marie-Tooth syndrome in identical twins. Birth Defects Orig. Art. Ser. VII(2): 105, 1971. [PubMed: 5173114]

  4. Ben Othmane, K. B., Rochelle, J. M., Hamida, M. B., Slotterbeck, B., Rao, N., Hentati, F., Pericak-Vance, M. A., Vance, J.M. Fine localization of the CMT4A locus using a PAC contig and haplotype analysis. Neurogenetics 2: 18-23, 1998. [PubMed: 9933296] [Full Text: https://doi.org/10.1007/s100480050047]

  5. Ben Othmane, K., Ben Hamida, M., Lennon, F., Loeb, D., Hentati, F., Ben Hamida, C., Blel, S., Pericak-Vance, M. A., Vance, J. M. Autosomal recessive Charcot-Marie-Tooth disease (CMT4) type A: evidence of genetic linkage to chromosome 8q21. (Abstract) Am. J. Hum. Genet. 53 (suppl.): A149, 1993.

  6. Ben Othmane, K., Hentati, F., Lennon, F., Ben Hamida, C., Blel, S., Roses, A. D., Pericak-Vance, M. A., Ben Hamida, M., Vance, J. M. Linkage of a locus (CMT4A) for autosomal recessive Charcot-Marie-Tooth disease to chromosome 8q. Hum. Molec. Genet. 2: 1625-1628, 1993. [PubMed: 8268915] [Full Text: https://doi.org/10.1093/hmg/2.10.1625]

  7. Ben Othmane, K., Loeb, D., Hayworth-Hodgte, R., Hentati, F., Rao, N., Roses, A. D., Ben Hamida, M., Pericak-Vance, M. A., Vance, J. M. Physical and genetic mapping of the CMT4A locus and exclusion of PMP-2 as the defect in CMT4A. Genomics 28: 286-290, 1995. [PubMed: 8530038] [Full Text: https://doi.org/10.1006/geno.1995.1143]

  8. Mahloudji, M. A recessively inherited mixed polyneuropathy of early onset. J. Med. Genet. 6: 411-412, 1969. [PubMed: 5365950] [Full Text: https://doi.org/10.1136/jmg.6.4.411]

  9. Nicholson, G., Ouvrier, R. GDAP1 mutations in CMT4: axonal and demyelinating phenotypes? (Editorial) Neurology 59: 1835-1836, 2002. [PubMed: 12499472] [Full Text: https://doi.org/10.1212/wnl.59.12.1835]

  10. Patzko, A., Shy, M. E. Charcot-Marie-Tooth disease and related genetic neuropathies. Continuum (Minneap. Minn.) 18: 39-59, 2012. [PubMed: 22810069] [Full Text: https://doi.org/10.1212/01.CON.0000411567.34085.da]

  11. Skre, H. Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin. Genet. 6: 98-118, 1974. [PubMed: 4430158] [Full Text: https://doi.org/10.1111/j.1399-0004.1974.tb00638.x]


Contributors:
Cassandra L. Kniffin - updated : 10/22/2012
Cassandra L. Kniffin - reorganized : 5/9/2003
Victor A. McKusick - updated : 1/21/2003
Victor A. McKusick - updated : 1/8/2002
Victor A. McKusick - updated : 4/12/1999

Creation Date:
Victor A. McKusick : 6/3/1986

Edit History:
carol : 01/03/2024
carol : 12/15/2015
ckniffin : 12/10/2015
alopez : 6/27/2013
ckniffin : 6/25/2013
carol : 10/23/2012
terry : 10/23/2012
ckniffin : 10/22/2012
ckniffin : 4/13/2011
carol : 4/22/2005
ckniffin : 4/20/2005
carol : 4/19/2005
wwang : 4/18/2005
ckniffin : 4/15/2005
ckniffin : 4/20/2004
carol : 12/12/2003
ckniffin : 12/12/2003
ckniffin : 5/29/2003
carol : 5/9/2003
ckniffin : 5/9/2003
ckniffin : 5/2/2003
ckniffin : 4/24/2003
ckniffin : 4/23/2003
ckniffin : 4/14/2003
cwells : 1/27/2003
tkritzer : 1/21/2003
terry : 3/22/2002
alopez : 1/9/2002
alopez : 1/9/2002
terry : 1/8/2002
carol : 5/18/2001
carol : 9/13/2000
carol : 4/12/1999
mark : 8/15/1996
mark : 3/5/1996
mark : 8/25/1995
carol : 6/16/1994
mimadm : 4/17/1994
warfield : 3/11/1994
carol : 10/18/1993
carol : 10/13/1993